...
首页> 外文期刊>International immunopharmacology >Methionine enkephalin (MENK) regulates the immune pathogenesis of type 2 diabetes mellitus via the IL-33/ST2 pathway
【24h】

Methionine enkephalin (MENK) regulates the immune pathogenesis of type 2 diabetes mellitus via the IL-33/ST2 pathway

机译:甲硫氨酸Enkephalin(MENK)通过IL-33 / ST2途径调节2型糖尿病的免疫发病机制

获取原文
获取原文并翻译 | 示例
           

摘要

The incidence and mortality of type 2 diabetes mellitus (T2DM) rank among the top ten worldwide. Emerging studies indicate pathological roles for the immune system in inflammation, insulin resistance and islet beta-cell damage in subjects with T2DM. Methionine enkephalin (MENK) is present in endocrine cells of the pancreas and has been suggested to be an important mediator between the immune and neuroendocrine systems. Therefore, it may play a role in modulating insulin secretion from islet cells. Since little is known about the effect of MENK on T2DM, therefore it was the aim of this study to characterize the role and possible mechanism of action of MENK on plasma glucose and serum insulin levels in T2DM rats and INS-1 cells in vivo and in vitro. MENK significantly decreased the plasma glucose level and increased the serum insulin concentration in T2DM rats. It also increased the serum levels of the cytokines IL-5 and IL-10, while decreased TNF-alpha and IL-2 levels. We further confirmed that MENK regulated glucose metabolism by upregulating opioid receptor expression and modulating the IL-33/ST2 and MyD88-TRAF6-NF-kappa B p65 signaling pathways. Based on these results, an intraperitoneal injection of MENK represents a potentially new approach for T2DM.
机译:第2型糖尿病的发病率和死亡率(T2DM)排名在全球十大。新兴研究表明免疫系统在炎症,胰岛素抵抗和胰岛β细胞损伤的病理作用,具有T2DM的受试者。甲硫氨酸脑脑(MENK)存在于胰腺的内分泌细胞中,并已建议是免疫和神经内分泌系统之间的重要介质。因此,它可能在调节胰岛细胞中调节胰岛素分泌中的作用。由于对MENK对T2DM的影响很少,因此本研究的目的是表征MENK在体内T2DM大鼠和INS-1细胞中的血浆葡萄糖和血清胰岛素水平的作用和可能机制。体外。 Menk显着降低了血浆葡萄糖水平,并增加了T2DM大鼠中的血清胰岛素浓度。它还增加了细胞因子IL-5和IL-10的血清水平,同时降低了TNF-α和IL-2水平。我们进一步证实,通过上调阿片受体的表达和调节IL-33 / ST2和MyD88-Traf6-NF-Kappa B P65信号传导途径,通过较新的Menk调节葡萄糖代谢。基于这些结果,腹膜内注射Menk代表了T2DM的潜在新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号